RESUMO
Primary and secondary malignant tumors can affect the parotid gland. The aim of this retrospective study was to evaluate the clinical features and prognosis of malignant epithelial tumors of the parotid gland. In particular, a comparison between primary and secondary cancer and survival analyses were performed. Eighteen patients with primary cancer and fifteen with intraparotid metastasis from cutaneous squamous cell carcinoma were included. A chart review was performed to collect clinical data (age, sex, smoking, alcohol consumption, tumor stage, type of surgical procedure, complications, recurrence and death). The majority of primary tumors were early (T1-2 N0, 83%) with mucoepidermoid carcinoma being the most common (33%). Secondary tumors were mostly staged P2 (53%) and N0 (67%). Subjects with secondary tumors were older than those with primary cancer. Post-operative permanent facial palsy was observed in 5 patients (17%) with primary cancer and 9 (60%) with secondary tumors (p = 0.010). Two-year overall survival for primary and secondary parotid cancer was 76.58% and 43.51%, respectively (p = 0.048), while 2-year disease-free survival was 76.05% and 38.50%, respectively (p = 0.152). In conclusion, secondary cancer of the parotid gland has worse survival than primary tumors. In the future, the implementation of multimodality treatment of intraparotid metastases is necessary to improve oncologic outcomes.
RESUMO
The Flex Robotic System is a device intended for robot-assisted visualization and surgical site access to the head and neck. The aim of this review is to summarize the current knowledge about the Flex Robotic System in head and neck transoral robotic surgery (TORS). The primary search was performed using the term "Flex Robot" across several databases (PubMed, Embase, Cochrane, Scopus). Patients were treated for both benign and malignant diseases. The oropharynx was the most frequent site of disease, followed by the supraglottic larynx, hypopharynx, glottic larynx, oral cavity, and salivary glands. Most of the studies did not reveal major intra- or post-operative complications. Bleeding incidence was low (1.4-15.7%). Visualization of the lesion was 95-100%, while surgical success was 91-100%. In conclusion, lesions of the oropharynx, hypopharynx, or larynx can be successfully resected, thus making the Flex Robotic System a safe and effective tool, reducing the morbidity associated with traditional open surgery.
RESUMO
Radiotherapy and chemotherapy represent important treatment modalities for head and neck cancer. Rhinosinusitis and smell alterations are common side effects in the sinonasal region. This review will summarize and analyze our current knowledge of the sinonasal side effects of chemotherapy and/or radiation therapy for head and neck cancer (HNC), with a specific focus on mucosal and olfactory disorders. A review of the English literature was performed using several databases (PubMed, Embase, Cochrane, Scopus). Fifty-six articles were included in qualitative synthesis: 28 assessed mucosal disorders (rhinitis or rhinosinusitis), 26 evaluated olfactory alterations, and 2 articles addressed both topics. The incidence and severity of olfactory dysfunction and chronic rhinosinusitis were highest at the end of radiotherapy and at three months after treatment and decreased gradually over time. Smell acuity deterioration and chronic rhinosinusitis seemed to be related to radiation dose on olfactory area and nasal cavities, but different degrees of recovery were observed. In conclusion, it is important to establish the severity of chronic rhinosinusitis and olfactory dysfunction in order to find strategies to support patients and improve their quality of life.
RESUMO
AIMS: QT interval may be considered an indirect marker of atrial repolarization. Aim of our study was to verify if QT interval variations precede the onset of atrial fibrillation (AF). METHODS: We analyzed 21 AF onsets recorded at 24-h Holter ECG. Triggering supraventricular extrabeats (TSVEB) were identified and matched to nontriggering supraventricular extrabeats (NTSVEB) with the same prematurity index. QT and QTc intervals and their variability (max-min QT interval) were measured in the 10 beats preceding TSVEB and NTSVEB. RESULTS: QTc (470.1â±â56.7 vs. 436.7â±â25.6 ms; Pâ=â0.006), QT (36.8â±â13.1 vs. 21.1â±â10.1 ms; Pâ=â0.001) and QTc variability (41.5â±â15.8 vs. 23.1â±â11.9; Pâ=â0.001) significantly varied between TSVEB and NTSVEB. By stratifying AF onsets in vagal (nâ=â10) and adrenergic (nâ=â11) according to Heart Rate Variability, significant differences emerged concerning QT (35.20â±â16.48 vs. 22.70â±â10.23 ms, Pâ=â0.006) and QTc variability (39.30â±â18.32 vs. 25.60â±â12.91 ms, Pâ=â0.029) for vagal onsets and QTc (477.73â±â57.50 vs. 438.00â±â28.55 ms, Pâ=â0.045), QT (38.36â±â9.79 vs. 19.73â±â10.21 ms, Pâ=â0.005) and QTc variability (43.55â±â13.72 vs. 20.82â±â11.01 ms, Pâ=â0.004) for adrenergic onsets. By stratifying AF onsets in type I (nâ=â7) or II (nâ=â14) according to a cycle length variation in the 30âs before the onset greater or smaller than 10% respectively, significant differences were noted concerning QTc (477.73â±â57.50 vs. 438â±â28.55 ms, Pâ=â0.045), QT (43.55â±â13.72 vs. 20.82â±â11.01 ms, Pâ=â0.005) and QTc variability (43.55â±â13.72 vs. 20.82â±â11.01 ms, Pâ=â0.004) in type I and QT (35.20â±â16.48 vs. 22.70â±â10.23 ms, Pâ=â0.006) and QTc variability (39.30â±â18.32 vs. 25.60â±â12.91 ms, Pâ=â0.029) in type II onsets. CONCLUSION: Prolongation and QT variability represent a relevant substrate marker in the genesis of AF, independently of the trigger type.